Low pre-radiotherapy prostate-specific antigen level is a significant predictor of treatment success for postoperative radiotherapy in patients with prostate cancer.
暂无分享，去创建一个
H. Honda | Y. Shioyama | S. Naito | T. Yoshitake | Katsumasa Nakamura | S. Ohga | Tomonari Sasaki | M. Abe | H. Terashima | H. Koga | T. Toba | A. Yamaguchi | Y. Urashima | T. Hirano | Y. Hiratsuka | H. Noma | K. Komatsu | K. Hanada | Y. Fujisawa | Madoka Abe